RT Journal Article
SR Electronic
T1 Communicating with patients and families about difficult matters: A rapid review in the context of the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20078048
DO 10.1101/2020.04.27.20078048
A1 Ekberg, Stuart
A1 Parry, Ruth
A1 Land, Victoria
A1 Ekberg, Katie
A1 Pino, Marco
A1 Antaki, Charles
YR 2020
UL http://medrxiv.org/content/early/2020/05/01/2020.04.27.20078048.abstract
AB Background Pandemics pose significant challenges for healthcare systems, including an increase in difficult discussions about future illness progression and end of life.Objectives To synthesise existing evidence about communication practices used to discuss difficult matters, including prognosis and end of life, and to use this evidence to make recommendations for clinical practice. The aim of this study was to use rapid review methods to update findings from a previous systematic review published in 2014.Data sources MEDLINE, EMBASE, CINAHL, PsycINFO, Sociological Abstracts, Web of Science, Scopus, ASSIA and Amed.Study eligibility criteria Studies using conversation analysis or discourse analysis to examine recordings of actual conversations about difficult matters relating to future illness progression and end of life.Study appraisal and synthesis methods Data appraisal and extraction procedures used in the 2014 review were modified for this rapid review.Results Following screening, 18 sources were deemed to meet eligibility criteria, which were added to the 19 sources included in the 2014 systematic review. Synthesis of study findings identified 11 communication practices: providing opportunities for patient or family members to propose matters to discuss (7 out of 37 included sources); seeking a patient or family member’s perspective (6/37); discussing the future indirectly (11/37); discussing the future explicitly (7/37) linking to something previously said or done (11/37); using hypothetical scenarios (13/37); framing a difficult matter as universal (5/37); acknowledging uncertainty (3/37); exploring options (2/37); displaying sensitivity (7/37); emphasising the positive (7/37).Limitations Dividing work amongst the study authors to enable rapid review may have created inconsistencies.Conclusions and implications of key findings This synthesis of high-quality evidence from actual clinical practice supports a series of recommendations for communicating about difficult matters during and beyond the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicable.Funding StatementNo research funding was obtained to support this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis article synthesises research findings that have already been published.